AnalystRadar
VRTX Updated Aug 13, 2026

Vertex Pharmaceuticals Incorporated (VRTX)

Analyst consensus, price target and coverage. 25 analysts, updated daily.

Consensus Buy= Unchanged
Price 525.73 USD
Mean target 563.12 USD
Upside +7.1% target vs price
Market cap Large 133.3B

Analyst votes

How the ratings break down

29 ratings on record

Price targets

Where the estimates sit

How far apart analysts are on this name.

Low 350.00 Mean 563.12 High 672.00

share price 525.73 mean target 563.12. Analysts are spread 92% apart.

Most recent action

Last rating change

FirmTruist Securities
Date2026-08-05
ChangeBuy → Buy

Size and liquidity

Key statistics

Market cap133.25B USD
Cap classLarge
Average volume1,576,859
Dollar volume per day829.0M
LiquidityHigh
Internal score70.9 / 100

Recommendation

How it moved, scan by scan

2 scans on record

ScanMoveConsensusScoreSBBuyHoldUndSell
2026-08-13 = Buy 2.14 4 19 5 0 1
2026-08-11 · Buy 2.14 4 19 5 0 1

Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. more positive, more negative, = unchanged.

History

Price target over time

2 daily points recorded

DatePriceTargetUpsideConsensus
2026-08-13 525.73 563.12 +7.1% Buy
2026-08-11 530.30 563.12 +6.2% Buy

Similar coverage

Comparable large-cap names

Closest upside among companies of the same size.

← All 1035 companies in the screener